FindTrial
Sign In

Chemotherapy selection for T3N0 rectal cancer

Chemotherapy selection for T3N0 rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046821
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-05-27
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T3N0 rectal cancer

Interventions

surgery group:Nil

Sponsors

The Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The pathological diagnosis was T3N0 rectal cancer; 2. Complete follow-up and survival data; 3. No NCRT; 4. Underwent TME; 5. Primary RC.

Exclusion criteria

Exclusion criteria: 1. The patient died suddenly..

Design outcomes

Primary

MeasureTime frame
moderate- and high-risk groups;—

Countries

China

Contacts

Public ContactWang Xudong

The Second Hospital of Jilin University

wangxud@jlu.edu.cn+86 13514406378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026